MiMedx Group, Inc. (MDXG)Healthcare | Biotechnology | Marietta, United States | NasdaqCM
4.08 USD
-0.03
(-0.730%) ⇩
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 4:08 a.m. EDT
The investment case here is fundamentally broken by a deteriorating business trajectory. While the balance sheet remains technically healthy with minimal debt, the core operational metrics tell a stark story: revenue has contracted by nearly one-third year-over-year, and the company is burning cash with operating margins deeply in the red. The market has rightly punished this reality, driving the stock down significantly over the last decade. Despite a 'strong buy' analyst recommendation based on potential turnaround narratives, the hard math of shrinking sales and negative cash flow suggests the current price is not a bargain but a reflection of a struggling enterprise. The lack of any dividend policy further eliminates income appeal. Short-term, the heavy put wall at $2.50 suggests a floor where buyers may step in, but without a confirmed reversal in the top-line growth trend, the long-term outlook remains precarious. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.078522 |
| AutoETS | 0.091420 |
| AutoARIMA | 0.091422 |
| AutoTheta | 0.100436 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 2.72 |
| Ljung-Box p | 0.001 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 5.79 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 7.242 |
| Revenue per Share | 2.63 |
| Market Cap | 607,698,560 |
| Trailing P/E | 20.40 |
| Forward P/E | 28.47 |
| Beta | 1.45 |
| Profit Margins | 7.88% |
| Website | https://www.mimedx.com |
As of July 11, 2026, 4:08 a.m. EDT: Speculators are positioning for a significant downside move, evidenced by heavy put volume and open interest concentrated at the $2.50 strike across multiple expirations. This creates a dense 'floor' of protection, suggesting a consensus expectation that the stock will test or breach this level. Conversely, call activity is sparse and heavily skewed toward out-of-the-money strikes ($5.00 and above), indicating limited speculative appetite for immediate upside despite the low implied volatility.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.39558822 |
| Address1 | 1,775 West Oak Commons Court, NE |
| All Time High | 18.25 |
| All Time Low | 0.35 |
| Ask | 5.17 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 1,488,270 |
| Average Daily Volume3 Month | 1,575,344 |
| Average Volume | 1,575,344 |
| Average Volume10Days | 1,488,270 |
| Beta | 1.446 |
| Bid | 2.98 |
| Bid Size | 2 |
| Board Risk | 7 |
| Book Value | 1.631 |
| City | Marietta |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 1 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.08 |
| Current Ratio | 5.395 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 4.135 |
| Day Low | 4.035 |
| Debt To Equity | 7.242 |
| Display Name | MiMedx |
| Earnings Call Timestamp End | 1,777,494,600 |
| Earnings Call Timestamp Start | 1,777,494,600 |
| Earnings Timestamp | 1,777,492,800 |
| Earnings Timestamp End | 1,785,355,200 |
| Earnings Timestamp Start | 1,785,355,200 |
| Ebitda | 52,882,000 |
| Ebitda Margins | 0.1358 |
| Enterprise To Ebitda | 8.803 |
| Enterprise To Revenue | 1.195 |
| Enterprise Value | 465,519,584 |
| Eps Current Year | -0.07 |
| Eps Forward | 0.14333 |
| Eps Trailing Twelve Months | 0.2 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.7116 |
| Fifty Day Average Change | 0.36839986 |
| Fifty Day Average Change Percent | 0.099256344 |
| Fifty Two Week Change Percent | -39.558823 |
| Fifty Two Week High | 7.99 |
| Fifty Two Week High Change | -3.9099998 |
| Fifty Two Week High Change Percent | -0.4893617 |
| Fifty Two Week Low | 3.03 |
| Fifty Two Week Low Change | 1.05 |
| Fifty Two Week Low Change Percent | 0.34653464 |
| Fifty Two Week Range | 3.03 - 7.99 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,202,826,600,000 |
| Float Shares | 117,957,572 |
| Forward Eps | 0.14333 |
| Forward P E | 28.465778 |
| Free Cashflow | 60,823,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 808 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.81043 |
| Gross Profits | 315,592,992 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02098 |
| Held Percent Institutions | 0.76716006 |
| Implied Shares Outstanding | 148,945,731 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,207,094,400 |
| Last Split Factor | 3,235:10000 |
| Long Business Summary | MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, EPIXPRESS, CHORIOFIX, EMERGE, CELERA, REGENKIT WOUND GEL, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX, AMNIOBURN, AMNIOCORD, AXIOFILL, HELIOGEN, and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company's products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. The company has a strategic alliance with Vaporox, Inc. for the promotion of their wound care offerings. The company was founded in 2006 and is headquartered in Marietta, Georgia. |
| Long Name | MiMedx Group, Inc. |
| Market | us_market |
| Market Cap | 607,698,560 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_35961030 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | 30,695,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 607,698,582 |
| Number Of Analyst Opinions | 5 |
| Open | 4.1 |
| Operating Cashflow | 70,583,000 |
| Operating Margins | -0.27206 |
| Overall Risk | 2 |
| Payout Ratio | 0.0 |
| Peg Ratio | 2.88 |
| Phone | 770 651 9100 |
| Previous Close | 4.11 |
| Price Eps Current Year | -58.285713 |
| Price Hint | 4 |
| Price To Book | 2.5015328 |
| Price To Sales Trailing12 Months | 1.5605383 |
| Profit Margins | 0.07882 |
| Quick Ratio | 4.62 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.2 |
| Region | US |
| Regular Market Change | -0.0300002 |
| Regular Market Change Percent | -0.729932 |
| Regular Market Day High | 4.135 |
| Regular Market Day Low | 4.035 |
| Regular Market Day Range | 4.035 - 4.135 |
| Regular Market Open | 4.1 |
| Regular Market Previous Close | 4.11 |
| Regular Market Price | 4.08 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 1,233,380 |
| Return On Assets | 0.08545 |
| Return On Equity | 0.13773 |
| Revenue Growth | -0.331 |
| Revenue Per Share | 2.63 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 1 |
| Shares Outstanding | 148,945,731 |
| Shares Percent Shares Out | 0.0505 |
| Shares Short | 7,527,408 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 7,578,242 |
| Short Name | MiMedx Group, Inc |
| Short Percent Of Float | 0.0636 |
| Short Ratio | 5.46 |
| Source Interval | 15 |
| State | GA |
| Symbol | MDXG |
| Target High Price | 8.0 |
| Target Low Price | 5.0 |
| Target Mean Price | 6.6 |
| Target Median Price | 6.0 |
| Total Cash | 159,772,992 |
| Total Cash Per Share | 1.073 |
| Total Debt | 17,594,000 |
| Total Revenue | 389,416,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.2 |
| Trailing P E | 20.4 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.26385 |
| Two Hundred Day Average Change | -1.1838503 |
| Two Hundred Day Average Change Percent | -0.22490197 |
| Type Disp | Equity |
| Volume | 1,233,380 |
| Website | https://www.mimedx.com |
| Zip | 30,062 |